Table 2 Baseline characteristics, cascade of care and time to TB treatment commencement and completion among participants who completed the telephonic survey, stratified by TB symptom status at baseline
| Â | Microbiologically-confirmed TB | Radiologically-suggested TB | ||||
|---|---|---|---|---|---|---|
Characteristic | Asymptomatic, N = 103a | Symptomatic, N = 19a | p-value | Asymptomatic, N = 122a | Symptomatic, N = 31a | p-value |
I. Baseline Characteristics | ||||||
Age group | Â | Â | 0.33 | Â | Â | 0.0393 |
 < 25 | 13 (13%) | 1 (5%) |  | 7 (6%) | 1 (3%) |  |
 25–44 | 38 (37%) | 4 (21%) |  | 26 (21%) | 1 (3%) |  |
 45–64 | 31 (30%) | 8 (42%) |  | 67 (55%) | 19 (61%) |  |
 > 65 | 21 (20%) | 6 (32%) |  | 22 (18%) | 10 (32%) |  |
Sex | Â | Â | 0.72 | Â | Â | 0.72 |
 Male | 48 (47%) | 8 (42%) |  | 67 (55%) | 16 (52%) |  |
 Female | 55 (53%) | 11 (58%) |  | 55 (45%) | 15 (48%) |  |
HIV ELISA | Â | Â | 0.92 | Â | Â | 0.112 |
 Negative | 56 (54%) | 10 (53%) |  | 55 (45%) | 19 (61%) |  |
 Positive | 47 (46%) | 9 (47%) |  | 67 (55%) | 12 (39%) |  |
CAD4TBv5 Score | 64 (45, 77) | 60 (55, 71) |  > 0.94 | 86 (70, 95) | 85 (74, 98) | 0.64 |
Residency location | Â | Â | 0.43 | Â | Â | 0.103 |
 Rural | 62 (60%) | 12 (63%) |  | 71 (58%) | 24 (77%) |  |
 Peri-urban | 39 (38%) | 6 (32%) |  | 42 (34%) | 7 (23%) |  |
 Urban | 2 (2%) | 1 (5%) |  | 9 (7%) | 0 (0%) |  |
Socioeconomic status | Â | Â | 0.53 | Â | Â | 0.33 |
 Lowest | 16 (16%) | 2 (11%) |  | 15 (12%) | 6 (19%) |  |
 Low | 29 (28%) | 10 (53%) |  | 33 (27%) | 11 (35%) |  |
 Middle | 26 (25%) | 3 (16%) |  | 28 (23%) | 3 (10%) |  |
 High | 13 (13%) | 2 (11%) |  | 22 (18%) | 7 (23%) |  |
 Highest | 15 (15%) | 2 (11%) |  | 18 (15%) | 3 (10%) |  |
 Unknown | 4 (4%) | 0 (0%) |  | 6 (5%) | 1 (3%) |  |
II. Cascade of care | ||||||
Attended clinic/hospital (self-reported) | 101 (98%) | 18 (95%) | 0.43 | 90 (74%) | 24 (77%) | 0.72 |
 Facility attended |  |  | 0.53 |  |  | 0.63 |
   Clinic | 98 (97%) | 17 (94%) |  | 22 (24%) | 4 (17%) |  |
   Hospital | 3 (3%) | 1 (6%) |  | 68 (76%) | 20 (83%) |  |
Started TB treatment (self-reported) | 98 (95%) | 17 (89%) | 0.33 | 19 (16%) | 5 (16%) |  > 0.93 |
Started TB treatment (Tier.net) | 72 (70%) | 16 (84%) | 0.23 | 11 (9%) | 4 (13%) | 0.53 |
Completed TB treatment (self-reported) | 96 (93%) | 17 (89%) | 0.33 | 17 (14%) | 5 (16%) | 0.83 |
III. Time to starting and completing TB treatment | ||||||
Time to starting TB treatment (days, self-reported) | 22 (14, 30) | 20 (10, 22) | 0.124 | 41 (31, 72) | 43 (42, 73) | 0.74 |
Time to starting TB treatment (days, Tier.net) | 9 (8, 24) | 26 (11, 29) | 0.144 | 45 (34, 58) | 66 (55, 79) | 0.24 |
Percentage of individuals starting TB treatment (by self-report) within: |  |  | 0.63 |  |  |  > 0.93 |
 0–30 days | 72 (73%) | 14 (82%) |  | 4 (21%) | 1 (20%) |  |
 31–60 days | 16 (16%) | 1 (6%) |  | 6 (32%) | 2 (40%) |  |
 61–90 days | 4 (4%) | 1 (6%) |  | 3 (16%) | 1 (20%) |  |
 More than 90 days | 4 (4%) | 0 (0%) |  | 4 (21%) | 1 (20%) |  |
 Unknown | 2 (2%) | 1 (6%) |  | 2 (11%) | 0 (0%) |  |
Time to completing TB treatment (days, self-report) | 208 (202, 218) | 205 (202, 216) | 0.34 | 259 (224, 292) | 255 (225, 257) | 0.74 |